NEW YORK – Proteomics firm Seer said on Wednesday that it has priced an underwritten public offering of 3.75 million shares of Class A common stock at $67 per share.
The offering will consist of 1.65 million shares sold by Seer and 2.1 million shares sold by stockholders of Seer. Gross proceeds to Seer will be around $110.5 million.
Additionally, the selling stockholders will grant the underwriters a 30-day option to purchase up to 562,500 additional shares of Class A common stock at the public offering price, less underwriting discounts and commissions.